DAL vs FDMT · P/E 12, rev $61.64B vs rev $37.0K
Delta Air Lines Inc (DAL) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the DAL and FDMT stock pages for the full models.
Not investment advice.